vanilmandelic acid has been researched along with Movement Disorders in 4 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rinne, UK | 1 |
| Siirtola, T | 1 |
| Sonninen, V | 1 |
| Messiha, FS | 1 |
| Senelick, RC | 1 |
| Bray, PF | 1 |
| Lahey, ME | 1 |
| VanDyk, HJ | 1 |
| Johnson, DG | 1 |
| Ericsson, AD | 1 |
| Wertman, BG | 1 |
4 other studies available for vanilmandelic acid and Movement Disorders
| Article | Year |
|---|---|
L-deprenyl treatment of on-off phenomena in Parkinson's disease.
Topics: Aged; Benserazide; Dopamine; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Hydroxyin | 1978 |
A study of biogenic amine metabolites in the cerebrospinal fluid and urine of monkeys with chlorpromazine-induced dyskinesia.
Topics: 5-Methoxytryptamine; Animals; Biogenic Amines; Chlorpromazine; Dopamine; Epinephrine; Female; Haplor | 1974 |
Neuroblastoma and myoclonic encephalopathy: two cases and a review of the literature.
Topics: Ataxia; Child, Preschool; Female; Humans; Infant; Male; Movement Disorders; Myoclonus; Neuroblastoma | 1973 |
Sensitivity studies of L-dopa metabolites in reserpinized rats and their clinical significance.
Topics: Animals; Brain; Catechols; Dihydroxyphenylalanine; Female; Humans; Male; Mandelic Acids; Middle Aged | 1971 |